Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study
Eligible age
18+ yrs
Accepts
All genders
Locations
6 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study investigates if circulating tumor DNA (ctDNA) and other tumor-related molecules/chemicals released in the blood can help doctors predict if colorectal cancer may come back or spread. Tumors shed DNA and other cancer related chemicals into the blood that can be identified and studied further to provide information about the cancer. Information gathered from this study may help researchers better understand if ctDNA found in the blood can predict whether colorectal cancer may come back or spread.
Sponsor: M.D. Anderson Cancer Center
You may qualify if…
- ✓ 1. Age ≥ 18 years.
- ✓ 2. Histological/cytological confirmation of colorectal adenocarcinoma.
- ✓ 3. Patients with any stage colorectal adenocarcinoma deemed potentially eligible for curative intent treatment. Patients with stages II-IV colorectal cancer post-R0 resection may also be enrolled onto the protocol any time before or up to 3 months post-surgery and prior to initiating adjuvant therapy.
- ✓ 4. Ability to understand and the willingness to sign a written informed consent document.
- ✓ 5. Willing to pursue standard of care surveillance post completion of curative therapies.
- ✓ 6. Willing to provide blood samples for correlative research.
You may not qualify if…
- ✕ 1. Known active malignancies other than colorectal adenocarcinoma that may interfere with detection and / or interpretation of circulating plasma markers. Patients with known clonal hematopoiesis of indeterminate potential are eligible.
- ✕ 2. Co-morbid systemic illnesses or other severe concurrent disease which, in the judgment of the investigator, would make the patient inappropriate for entry into this study.
Where it's recruiting
Source: ClinicalTrials.gov · NCT04739072 · last updated 2026-05-29